Millions for Proteomics Research in the Peer Reviewed Medical Research Program
Millions for Proteomics Research in the Peer Reviewed Medical Research Program
How SomaLogic technologies can give your research programs an edge.
Topics Covered
- Overview of the Peer Reviewed Medical Research Program (PRMRP) and Congressionally Directed Medical Research Programs (CDMRP)
- Overview of SomaLogic technologies that can give your research programs an edge
- How the PRMRP application process is unique to other U.S. government grant programs
- “Best Practices” for a successful PRMRP application
Tammy Hicks
Tammy Hicks is the Associate Director for the Southeast U.S. for SomaLoigic and has over 24 years of experience leading, mentoring, and selling in the Life Sciences market. She has supported many sectors, including academic research centers, pharmaceutical companies, and diagnostic testing providers. Tammy’s understanding of research and how to translate research findings into practical, actionable information for patients and physicians alike has allowed her to assist with many projects that improve health outcomes and deepen our understanding of human biology.
Elizabeth Barrows
Elizabeth “Liz” Barrows is a federal funding consultant whose clients have secured in excess of $100M over the course of her 10+-year career. Liz’s in-depth knowledge of the Department of Defense (DoD) funding opportunities and needs has a basis in experience at the DoD, where she managed pharmaceutical research and development projects in, and reviewed proposals for, blood products, resuscitation fluids and analgesic drugs for the U.S. Army from 2004-2009. She has also worked with NASA and private industry on the development of biomedical sensors, robotics, in vitro diagnostics, and blood products. She holds a master’s degree in biomedical engineering.
Millions for Proteomics Research in the Peer Reviewed Medical Research Program
A presentation by Tammy Hicks and Elizabeth Barrows
More webinars
WebinarRethinking Neurodegeneration Through Blood-Based Biomarkers
Proteomics is reshaping how we predict, diagnose, and understand neurodegenerative diseases. In this roundtable, leading experts Tony Wyss-Coray, PhD, and Jacob Vogel, PhD, explore the power of blood-based biomarkers, from deep molecular studies to global-scale datasets using the SomaScan™ Assay. They discuss how protein signatures can reveal brain aging, predict dementia, and track changes in disease pathways over time, with moderation by Steve Williams, MD, PhD. Learn how cutting-edge proteomics is redefining what is possible in neurological research.
WebinarProteomics in Clinical Trials: Lessons from Semaglutide Treatment in Individuals with Obesity
Advancements in proteomic profiling have opened new avenues for understanding the complex mechanisms underlying obesity and its comorbidities. By measuring thousands of proteins at once, researchers gain a comprehensive view of an individual’s metabolic health, revealing subclinical processes and pinpointing potential therapeutic targets.
WebinarPathways to Digital Health: AI and Omics in Rheumatoid Arthritis
Explore how groundbreaking proteomic research is transforming our understanding of rheumatoid arthritis (RA). In this on-demand webinar, Allan Stensballe, PhD, shares new insights into the molecular landscape of RA-affected synovial tissue, revealing how autoantibodies and protein signatures may hold the key to more precise personalized therapies.